Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.

ABSTRACT:

Background and aims

Prior reports have demonstrated a favourable safety and efficacy profile of the Micra leadless pacemaker over mid-term follow-up; however, long-term outcomes in real-world clinical practice remain unknown. Updated performance of the Micra VR leadless pacemaker through five years from the worldwide post-approval registry (PAR) was assessed.

Methods

All Micra PAR patients undergoing implant attempts were included. Endpoints included system- or procedure-related major complications and system revision rate for any cause through 60 months post-implant. Rates were compared through 36 months post-implant to a reference dataset of 2667 transvenous pacemaker patients using Fine-Gray competing risk models.

Results

1809 patients were enrolled between July 20

SUBMITTER: El-Chami MF 

PROVIDER: S-EPMC10998730 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature